Brand Manager
Responsibilities:
- Formulate and implement marketing plan
- Drive online and offline advertising and promotion initiatives to maximize brand awareness and business growth
- Work closely with external suppliers for new product development
- Work closely with distributors and advertising agencies to execute new product launch and trade promotion
- Work closely with internal parties to plan for new brand and product development
- Monitor market trends, competition and keep track of market intelligence
Requirements:
- Degree in marketing or related discipline
- 3-5 years’ solid experience in F&B and/or PC category
- Fast paced, creative, analytical minded with strong business acumen
- Team player with excellent interpersonal and communication skills
- Good command of spoken and written English and Chinese especially Putonghua
- Not mandatory but would be an advantage to have E-Commerce experience
- Must have experience in product development & project management
- Less experience candidate will be considered as Assistant Brand Manager
Salary and benefits will be commensurate with experience. Please send detailed resume with current and expected salary by clicking Apply Now
We are an equal opportunity employer and welcome applications from all qualified candidates. The information provided will be treated in strict confidence and used only for consideration of application for relevant/similar post(s) within the CK Hutchison Group of Companies. Applicants not having heard from us within four weeks from the date of this advertisement may consider their application unsuccessful. All personal data of unsuccessful applicants will be destroyed after the recruitment exercise when no longer required.
| Job ref no. | CT3128879-01#0049 |
| Salary | |
| Job Function | |
| Industry | |
| Location |
|
| Employment Term |
|
| Experience |
|
| Career Level |
|
| Education |
|
)Hutchison China MediTech Limited, known as Chi-Med, is an innovative biopharmaceutical company aiming to become a global leader in the discovery, development and commercialisation of targeted therapies for oncology and immunological diseases.
Chi-Med is listed on the London Stock Exchange’s AIM market and on the Nasdaq Global Select Market (AIM/Nasdaq: HCM). It is majority owned by CK Hutchison Holdings Limited (SEHK: 0001), a leading international conglomerate committed to innovation and technology with over a quarter of a million employees in more than 50 countries and annual sales of over US$50 billion.
Chi-Med’s Innovation Platform has developed and progressed a broad pipeline of novel oral drug candidates for cancer and inflammation which is in development in North America, Europe, Greater China and Australia. Chi-Med has also developed a profitable Commercial Platform, which manufactures, markets and distributes prescription drugs and consumer health products.